We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$9.77M
3
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.48M
4
MSFT icon
Microsoft
MSFT
+$4.93M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.9M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$7.34M
2
SBUX icon
Starbucks
SBUX
+$4.7M
3
CMF icon
iShares California Muni Bond ETF
CMF
+$3.3M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$2.63M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NPCE icon
3401
Neuropace
NPCE
$506M
$167 ﹤0.01%
15
-4
-21% -$50
ATLC icon
3402
Atlanticus Holdings
ATLC
$1.52B
$164 ﹤0.01%
+3
New +$156
AMRN
3403
Amarin Corp
AMRN
$303M
$162 ﹤0.01%
10
– –
ORGN
3404
DELISTED
Origin Materials
ORGN
$161 ﹤0.01%
11
– –
SLYV icon
3405
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
$160 ﹤0.01%
+2
New +$152
ALT icon
3406
Altimmune
ALT
$599M
$155 ﹤0.01%
40
– –
IOVA icon
3407
Iovance Biotherapeutics
IOVA
$2.87B
$148 ﹤0.01%
86
– –
QNST icon
3408
QuinStreet
QNST
$1.21B
$145 ﹤0.01%
+9
New +$144
BSLK
3409
DELISTED
Bolt Projects Holdings
BSLK
$141 ﹤0.01%
+50
New +$221
ANGI icon
3410
Angi Inc
ANGI
$196M
$137 ﹤0.01%
9
+2
+29% +$29
TEAD
3411
Teads Holding Co
TEAD
$67.7M
$134 ﹤0.01%
54
+17
+46% +$51
UUP icon
3412
Invesco DB US Dollar Index Bullish Fund
UUP
$422M
$134 ﹤0.01%
+5
New +$138
XME icon
3413
State Street SPDR S&P Metals & Mining ETF
XME
$4.42B
$134 ﹤0.01%
2
– –
EDIT icon
3414
Editas Medicine
EDIT
$442M
$132 ﹤0.01%
60
– –
SIBN icon
3415
SI-BONE Inc
SIBN
$834M
$132 ﹤0.01%
7
-20
-74% -$332
XT icon
3416
iShares Future Exponential Technologies ETF
XT
$3.97B
$131 ﹤0.01%
+2
New +$119
KLRS
3417
Kalaris Therapeutics
KLRS
$96.8M
$131 ﹤0.01%
49
– –
BKT icon
3418
BlackRock Income Trust
BKT
$341M
$129 ﹤0.01%
+11
New +$127
CLMT icon
3419
Calumet Specialty Products
CLMT
$3.44B
$126 ﹤0.01%
+8
New +$102
ISTR icon
3420
Investar Holding Corp
ISTR
$414M
$125 ﹤0.01%
6
– –
CON
3421
Concentra Group Holdings
CON
$4.36B
$123 ﹤0.01%
6
-68
-92% -$1.45K
TPST icon
3422
Tempest Therapeutics
TPST
$14.6M
$122 ﹤0.01%
18
– –
CURV icon
3423
Torrid Holdings
CURV
$260M
$121 ﹤0.01%
41
– –
GSAT icon
3424
Globalstar
GSAT
$10.8B
$118 ﹤0.01%
5
– –
ACB
3425
Aurora Cannabis
ACB
$185M
$114 ﹤0.01%
+27
New +$131
135 136
137
138 139

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.